RNA
Avidity Biosciences Inc
NASDAQ · Biotechnology
$72.90
+0.08 (+0.11%)
Performance
1D
—
1W
+0.22%
1M
+0.76%
3M
+3.11%
6M
+57.96%
1Y
+112.47%
YTD
+1.11%
Open$72.92
Previous Close$72.82
Day High$72.95
Day Low$72.79
52W High$73.06
52W Low$21.51
Volume3.16M
Avg Volume2.23M
Market Cap10.99B
P/E Ratio—
EPS$-4.17
SectorBiotechnology
Volume Analysis
1.42x average volume
Technical Indicators
SMA 50
$72.17
Above
SMA 200
$49.92
Above
RSI (14)
62.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
15 analysts
Price Target
+140.9% upside
Current
$72.90
$72.90
Target
$175.59
$175.59
$142.96
$175.59 avg
$272.35
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 14.73M | 13.99M | 2.64B |
| Net Income | -435,440,146 | -372,135,724 | -726,828,585 |
| Profit Margin | -2,957.7% | -2,809.8% | -27.5% |
| EBITDA | -508,538,615 | -458,751,955 | -980,937,033 |
| Free Cash Flow | — | — | -510,766,902 |
| Rev Growth | +5.3% | +5.3% | +2.7% |
| Debt/Equity | — | — | 0.62 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |